These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12014629

  • 1. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma.
    Insug O, Ku G, Ertl HC, Blaszczyk-Thurin M.
    Anticancer Res; 2002; 22(2A):613-21. PubMed ID: 12014629
    [Abstract] [Full Text] [Related]

  • 2. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H, Tsugawa T, Sato H, Kuwashima N, Gambotto A, Okada K, Dusak JE, Fellows-Mayle WK, Papworth GD, Watkins SC, Chambers WH, Potter DM, Storkus WJ, Pollack IF.
    Cancer Res; 2004 Aug 15; 64(16):5830-8. PubMed ID: 15313927
    [Abstract] [Full Text] [Related]

  • 3. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL.
    Cancer Res; 2001 Feb 01; 61(3):842-7. PubMed ID: 11221866
    [Abstract] [Full Text] [Related]

  • 4. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.
    Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM.
    Cancer Res; 2002 Apr 15; 62(8):2287-93. PubMed ID: 11956085
    [Abstract] [Full Text] [Related]

  • 5. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.
    Int J Oncol; 2006 Apr 15; 28(4):947-53. PubMed ID: 16525645
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.
    Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ.
    Cancer Res; 2004 Jul 15; 64(14):4973-9. PubMed ID: 15256471
    [Abstract] [Full Text] [Related]

  • 7. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H.
    Gene Ther; 2004 Nov 15; 11(21):1551-8. PubMed ID: 15343358
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
    Akasaki Y, Kikuchi T, Homma S, Abe T, Kofe D, Ohno T.
    J Immunother; 2001 Nov 15; 24(2):106-13. PubMed ID: 11265767
    [Abstract] [Full Text] [Related]

  • 9. Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor model.
    Schmidt T, Ziske C, Märten A, Endres S, Tiemann K, Schmitz V, Gorschlüter M, Schneider C, Sauerbruch T, Schmidt-Wolf IG.
    Cancer Res; 2003 Dec 15; 63(24):8962-7. PubMed ID: 14695214
    [Abstract] [Full Text] [Related]

  • 10. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
    Saha A, Chatterjee SK, Foon KA, Primus FJ, Bhattacharya-Chatterjee M.
    Cancer Res; 2003 Jun 01; 63(11):2844-54. PubMed ID: 12782590
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X, Hu J, Belladonna ML, Black KL, Yu JS.
    Cancer Res; 2006 Mar 01; 66(5):2630-8. PubMed ID: 16510582
    [Abstract] [Full Text] [Related]

  • 12. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
    Li Q, Zhang Y, Chen XH, Cao WX, Gu QL, Zhu ZG, Liu BY.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar 01; 9(2):148-51. PubMed ID: 16555158
    [Abstract] [Full Text] [Related]

  • 13. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
    Kao JY, Zhang M, Chen CM, Pierzchala A, Chen JJ.
    Immunol Lett; 2006 May 15; 105(1):16-25. PubMed ID: 16388858
    [Abstract] [Full Text] [Related]

  • 14. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW, Ksander BR.
    Curr Eye Res; 2006 Jan 15; 31(1):43-55. PubMed ID: 16421019
    [Abstract] [Full Text] [Related]

  • 15. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
    Jung CW, Kwon JH, Seol JG, Park WH, Hyun JM, Kim ES, Kim ST, Lee SJ, Kim BK, Lee YY.
    Am J Hematol; 2004 Mar 15; 75(3):121-7. PubMed ID: 14978690
    [Abstract] [Full Text] [Related]

  • 16. Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Miyagi T, Jinushi M, Sakamori R, Kohga K, Uemura A, Ohkawa K, Storkus WJ, Hayashi N.
    Gene Ther; 2007 Jun 15; 14(11):863-71. PubMed ID: 17344900
    [Abstract] [Full Text] [Related]

  • 17. Immunotherapy of intracranial G422 glioblastoma with dendritic cells pulsed with tumor extract or RNA.
    Zhang Z, Tang LL, Zhan RY, Tong Y, Yao HP, Du LA.
    J Zhejiang Univ Sci; 2004 Oct 15; 5(10):1298-303. PubMed ID: 15362204
    [Abstract] [Full Text] [Related]

  • 18. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 15; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.
    Clin Immunol; 2009 Nov 15; 133(2):184-97. PubMed ID: 19664962
    [Abstract] [Full Text] [Related]

  • 20. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity.
    Hokey DA, Larregina AT, Erdos G, Watkins SC, Falo LD.
    Cancer Res; 2005 Nov 01; 65(21):10059-67. PubMed ID: 16267032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.